Detalles de la búsqueda
1.
Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.
Future Oncol
; 17(35): 4959-4969, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34783255
2.
Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.
BMC Cancer
; 20(1): 276, 2020 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32248816
3.
Real-world incidence and cost of pneumonitis post-chemoradiotherapy for Stage III non-small-cell lung cancer.
Future Oncol
; 16(1): 4303-4313, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802700
4.
Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer.
Future Oncol
; 15(29): 3381-3393, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31544510
5.
Real-world treatment patterns among patients with unresected stage III non-small-cell lung cancer.
Future Oncol
; 15(25): 2943-2953, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31037966
6.
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study.
Blood Adv
; 8(9): 2085-2093, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315043
7.
The burden of influenza B: a structured literature review.
Am J Public Health
; 103(3): e43-51, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23327249
8.
Association of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysis.
BMC Infect Dis
; 13: 334, 2013 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-23870086
9.
Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States.
Expert Rev Pharmacoecon Outcomes Res
; 23(5): 579-589, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36987886
10.
Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia.
Blood Adv
; 7(16): 4291-4301, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37163361
11.
Health disparity in use of novel agents for first-line therapy in Black and White patients with chronic lymphocytic leukemia in the Department of Veterans Affairs.
J Manag Care Spec Pharm
; 29(4): 420-430, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36989449
12.
Time and personnel costs associated with adverse event (AE) management among patients with chronic lymphocytic leukemia (CLL).
Expert Rev Pharmacoecon Outcomes Res
; 23(6): 651-658, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021518
13.
Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.
Target Oncol
; 18(5): 727-734, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37728835
14.
Oncologist and Patient Preferences for Novel Agents in First-Line Treatment for Chronic Lymphocytic Leukemia: Commonalities and Disconnects.
Patient Prefer Adherence
; 15: 99-110, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33519195
15.
Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System.
Leuk Lymphoma
; 62(7): 1664-1673, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569992
16.
Clinical and economic outcomes in Medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: the role of intravenous iron therapy.
J Manag Care Pharm
; 16(8): 605-15, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20866165
17.
Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer.
J Manag Care Spec Pharm
; 26(6): 729-740, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32463768
18.
Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer.
PLoS One
; 15(3): e0230444, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32187231
19.
The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection.
Infect Drug Resist
; 12: 329-343, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30774399
20.
Real-world outcomes in patients with unresected stage III non-small cell lung cancer.
Med Oncol
; 36(3): 24, 2019 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-30706218